Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of liposomal bupivacaine in PENG and lateral femoral cutaneous nerve blocks for total hip arthroplasty
ChiCTR2500103535Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- May 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of liposomal bupivacaine and bupivacaine in postoperative pain (3 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Plasma bupivacaine concentration over time. Started May 2025; status: recruiting.
02
Drugs
liposomal bupivacainebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500103535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103535.